Difference between revisions of "Kummar S, et al. J. Clin. Oncol. (2017) cited as Ref 591 in DOI: 10.1038/s41392-020-0110-5 (Q9854)"
Jump to navigation
Jump to search
(Created claim: Volume (P103): 35, #quickstatements; #temporary_batch_1590009084631) |
(Created claim: title (P93): Clinical activity of the gamma-secretase inhibitor PF-03084014 in adults with desmoid tumors (aggressive fibromatosis), #quickstatements; #temporary_batch_1590010982689) |
||
| Property / title | |||
| + | Clinical activity of the gamma-secretase inhibitor PF-03084014 in adults with desmoid tumors (aggressive fibromatosis) (English) | ||
| Property / title: Clinical activity of the gamma-secretase inhibitor PF-03084014 in adults with desmoid tumors (aggressive fibromatosis) (English) / rank | |||
| + | Normal rank | ||
Revision as of 22:04, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Kummar S, et al. J. Clin. Oncol. (2017) cited as Ref 591 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Kummar S
0 references
2017
0 references
J. Clin. Oncol.
0 references
35
0 references
Clinical activity of the gamma-secretase inhibitor PF-03084014 in adults with desmoid tumors (aggressive fibromatosis) (English)
0 references
